The campaign is purposefully online, given many people’s preference to consume information that way and making it more convenient to access. Asthma can be triggered by environmental factors, such as pollen, smoke, weather changes or exercise. We believe our combined experience will provide you with the most complete solutions to meet your needs. © 2019 Genzyme Corporation. This year, we are encouraging action—inspiring people to take proactive steps towards better asthma control. For people living with severe asthma, that can be 8.4 million moments of worry. They say ‘Oh, it’s just normal that I can’t climb the stairs or play with my grandkids’ or do other activities that are quite frankly normal for everyone else. According to the Centers for Disease Control and Prevention, more than 45% of people with asthma reported one or more asthma attacks. RELATED: Roving poison ivy, crawling insects and a real patient star in Dupixent's first ads. It can be caused by an overactive immune system, which can lead to inflammation in the airways, causing them to narrow and making it harder to breathe. Between 5% and 10% of asthma cases are classified as severe and can be harder to control, disrupting day-to-day lives even when multiple controller medicines are used. Last year, Sanofi and Regeneron launched The Next Breath to bring more awareness to severe asthma. 3 Speen Street, Suite 300, Framingham, MA 01701. Next Breath is a full service cGMP compliant laboratory specializing in analytical testing of drug delivery systems from early stage to commercialization. This webinar will explore why adherence, safety and quality of life are important for patients, and how these key enablers contribute towards positive outcomes. These factors can lead to inflammation, causing the onset or worsening of asthma symptoms. This website uses cookies to track its audience and improve its content. This year, we are encouraging action—inspiring people to take proactive steps towards better asthma control. Sanofi and Regeneron's IL-4 and IL-13 blocker Dupixent was first approved to treat atopic dermatitis in 2017, and it picked up an FDA nod in the fall to treat moderate and severe asthma patients with an eosinophilic phenotype or those who are dependent on an oral corticosteroid. How will it impact my life? The investments will be used to add new manufacturing and lab spaces as well as installing new technologies. Use your next breath to drive AWARENESS SUPPORT SCIENCE EMPOWERMENT ACTION The Next Breath aims to bring more awareness to severe asthma, illuminate the latest science and empower people to take action to strive towards better asthma control. “Patients learn to live with a lot of these things. It is time to turn those moments of worry into moments of possibility. We will also discuss existing challenges, such as drug development, regulatory, patient accessibility, and how device technologies can further improve patient outcomes. Asthma is a chronic condition that affects the airways. RELATED: Sanofi's Dupixent set for $2.5B in peak asthma sales after scoring winning label: analyst. Last year, Sanofi and Regeneron launched The Next Breath to bring more awareness to severe asthma. Asthma that isn’t well controlled is also known as uncontrolled or persistent asthma. Welcome to The Next Breath Blog, where you'll find personal stories from people with severe asthma, tips and resources, and information on the latest science in asthma. How will it impact my life? Sanofi’s own research found that up to 50% of asthma patients who have reported severe symptoms still consider their asthma to be well controlled, said Brian Foard, global lead for dermatology and respiratory at Sanofi Genzyme. Inflating lungs anchor Sanofi and Regeneron's homepage for "The Next Breath" awareness effort to highlight severe asthma. All rights reserved. Click here for more information on cookies. All rights reserved. So we really think that’s important to really shine a light on for this asthma community,” Foard said. In 50-70% of people with asthma, this inflammation is called type 2 inflammation. Sanofi Genzyme et Regeneron sont des marques déposées. “We have a pretty significant ambition in this specialty respiratory space and bringing good quality care to these patients,” Foard said. Sanofi, Regeneron dive deep on asthma in debut digital awareness campaign, Sanofi's Dupixent set for $2.5B in peak asthma sales after scoring winning label: analyst, Roving poison ivy, crawling insects and a real patient star in Dupixent's first ads, Orchard gene therapy Strimvelis linked to a leukemia case, Novavax expands in Maryland as COVID, flu vaccines move forward, Pfizer to invest €300M in 3 Irish manufacturing sites. What will my next breath bring? “The Next Breath” campaign, … Dupixent is just one of many newer biologic asthma treatments vying for market share along with GlaxoSmithKline’s Nucala, Teva Pharmaceutical’s Cinqair, AstraZeneca’s Fasenra, and Roche and Novartis’ Xolair. Enclose phrases in quotes. This is just the beginning of the work, Foard said, anticipating that it will continue and evolve with new information and input in the future. Sanofi and Regeneron's biologic Dupixent added an indication for asthma in October. Subscribe to FiercePharma to get industry news and updates delivered to your inbox. Starting the Countdown to Better Asthma Control, Click here for more information on cookies. Between 5% and 10% of asthma cases are classified as severe and can be harder to control, disrupting day-to-day lives even when multiple controller medicines are used. Posts on social media sites Twitter and Facebook are meant to drive traffic to the website. starting-the-countdown-to-better-asthma-control. These factors can lead to inflammation, causing the onset or worsening of asthma symptoms. Therapies requiring high volume injections are becoming more common across a broad range of therapeutic areas. The Next Breath est une initiative mondiale de Sanofi Genzyme & Regeneron. ... Sanofi Genzyme and Regeneron do not review the information contained on this website and/or database for content, accuracy, or completeness. The Next Breath Editorial Team 12/5/2019 12:00:00 AM Dr. Lawrence Sher, Medical Director at Palos Verdes Medical Group and a physician at Peninsula Research Associates, discusses type 2 inflammation, an underlying cause of a certain type of asthma, 1 and what true asthma “control” could look like. Counting Down to Better Asthma Control Asthma is a chronic condition that affects the airways. Since its EU approval in 2016, only 16 patients have been treated with Stimvelis, which was originally co-developed by GlaxoSmithKline. This year, we are encouraging action—inspiring people to take proactive steps towards better asthma control. Sanofi and Regeneron’s new online disease awareness campaign highlights the problems of uncontrolled asthma. Thanks to the promise of Novavax's COVID-19 vaccine and a separate flu program, the company is expanding its Maryland campus. Asthma can be triggered by environmental factors, such as pollen, smoke, weather changes or exercise. Register Today! exclude terms. Use a + to require a term in results and - to Last year, Sanofi and Regeneron launched The Next Breath to bring more awareness to severe asthma. Sanofi and Regeneron’s new online disease awareness campaign highlights the problems of uncontrolled asthma. This year, we are encouraging action—inspiring people to take proactive steps towards better asthma control. Visit The Next Breath to learn more about severe asthma, the latest science, and actions you can take to strive towards better asthma control. © 2020 Questex LLC. Reproduction in whole or part is prohibited. What will my next breath bring? Between 5% and 10% of asthma cases are classified as severe and can be harder to control, disrupting day-to-day lives even when multiple controller medicines are used. “The Next Breath” campaign, launched on World Asthma Day in May, aims to make patients, caregivers and others aware that uncontrolled moderate to severe asthma can have a big impact on daily life. On the website, several patients tell their personal stories about living with uncontrolled asthma in videos. Asthma that isn’t well controlled is also known as uncontrolled or persistent asthma. (Sanofi), How technologies are transforming high volume injections - essential enablers for patient outcomes. Visit The Next Breath to learn more about severe asthma, the latest science, and actions you can take to strive towards better asthma control. By continuing to browse this website, you agree to the use of such cookies. The Next Breath Editorial Team 12/5/2019 12:00:00 AM Dr. Lawrence Sher, Medical Director at Palos Verdes Medical Group and a physician at Peninsula Research Associates, discusses type 2 inflammation, an underlying cause of a certain type of asthma, 1 … It is time to turn those moments of worry into moments of possibility. For people living with severe asthma, that can be 8.4 million moments of worry. Next Breath believes in building strategic relationships with leading industry experts and organizations allowing us to collaborate and benefit from their collective experience. Most people know what asthma is, but even asthma patients can underestimate it. Last year, Sanofi and Regeneron launched The Next Breath to bring more awareness to severe asthma. By continuing to browse this website, you agree to the use of such cookies. Asthma is a chronic condition that affects the airways. The average person takes 8.4 million breaths every year. Sanofi Genzyme & Regeneron- Tous droits réservés. In 50-70% of people with asthma, this inflammation is called type 2 inflammation. It can be caused by an overactive immune system, which can lead to inflammation in the airways, causing them to narrow and making it harder to breathe. Asthma that isn’t well controlled is also known as uncontrolled or persistent asthma. The average person takes 8.4 million breaths every year. This website uses cookies to track its audience and improve its content. It is time to turn those moments of worry into moments of possibility. This site is intended for United States residents only.